Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biochemistry

• Publication date

  2007-06-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI700496WPMID 17530866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crystal structure of CETP: new hopes for raising HDL to decrease risk of cardiovascular disease?

  2007cited by this paper
• Effects of salt on the thermal stability of human plasma high-density lipoprotein.

  2006cited by this paper
• Serum Opacity Factor, a Streptococcal Virulence Factor That Binds to Apolipoproteins A-I and A-II and Disrupts High Density Lipoprotein Structure*

  2006cited by this paper
• Dissociation of apolipoprotein AI from apoprotein-lipid complexes and from high-density lipoproteins. A fluorescence study.

  2005cited by this paper
• Remodeling of human plasma lipoproteins by detergent perturbation.

  2005cited by this paper
• ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I

  2005cited by this paper
• SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500068-JLR200

  2005cited by this paper
• α-Helix Formation Is Required for High Affinity Binding of Human Apolipoprotein A-I to Lipids*

  2004cited by this paper
• ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.

  2004cited by this paper
• Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.M300257-JLR200

  2004cited by this paper
• ApoA-II modulates the association of HDL with class B scavenger receptors SR-BI and CD36 Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.M300417-JLR200

  2004cited by this paper
• Expression and Regulation of Multiple Murine ATP-binding Cassette Transporter G1 mRNAs/Isoforms That Stimulate Cellular Cholesterol Efflux to High Density Lipoprotein*

  2004cited by this paper
• Domain Structure and Lipid Interaction in Human Apolipoproteins A-I and E, a General Model*

  2003cited by this paper
• Human plasma high-density lipoproteins are stabilized by kinetic factors.

  2003cited by this paper
• The fate of HDL particles in vivo after SR-BI-mediated selective lipid uptake Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200173-JLR200

  2002cited by this paper
• The human ABCG4 gene is regulated by oxysterols and retinoids in monocyte-derived macrophages.

  2001cited by this paper
• Cellular cholesterol efflux.

  2001cited by this paper
• Apolipoprotein A-II Modulates the Binding and Selective Lipid Uptake of Reconstituted High Density Lipoprotein by Scavenger Receptor BI*

  2001cited by this paper
• High Density Lipoprotein Phospholipid Composition Is a Major Determinant of the Bi-directional Flux and Net Movement of Cellular Free Cholesterol Mediated by Scavenger Receptor BI*

  2000cited by this paper
• Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid.

  1997cited by this paper
• Evidence That Cholesteryl Ester Transfer Protein-mediated Reductions in Reconstituted High Density Lipoprotein Size Involve Particle Fusion*

  1997cited by this paper
• The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.

  1996cited by this paper
• Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase.

  1996cited by this paper
• Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor

  1996cited by this paper
• Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides.

  1995cited by this paper
• The Effect of High Density Lipoprotein Phospholipid Acyl Chain Composition on the Efflux of Cellular Free Cholesterol (*)

  1995cited by this paper
• Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

  1995cited by this paper
• Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol.

  1992cited by this paper
• Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol.

  1991cited by this paper
• Lipid transfer particle-induced transformation of human high density lipoprotein into apolipoprotein A-I-deficient low density particles.

  1990cited by this paper
• Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

  1988cited by this paper
• Mechanisms and consequences of cellular cholesterol exchange and transfer.

  1987cited by this paper
• Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

  1987cited by this paper
• Partially Reassembled High Density Lipoproteins: Effects on Cholesterol Flux, Synthesis, and Esterification in Normal Human Skin Fibroblasts

  1986cited by this paper
• Influence of molecular packing and phospholipid type on rates of cholesterol exchange.

  1986cited by this paper
• The bidirectional flux of cholesterol between cells and lipoproteins. Effects of phospholipid depletion of high density lipoprotein.

  1986cited by this paper
• Factors affecting the integrity of high density lipoproteins in the ultracentrifuge.

  1982cited by this paper
• Mechanism of dissociation of human apolipoprotein A-I from complexes with dimyristoylphosphatidylcholine as studied by guanidine hydrochloride denaturation.

  1982cited by this paper
• A method for the synthesis of isomerically pure saturated mixed-chain phosphatidylcholines.

  1981cited by this paper
• A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

  1978cited by this paper
• Effect of pressure and ionic strength on the self-association of Apo-A-I from the human high density lipoprotein complex.

  1978cited by this paper
• Effects of guanidine hydrochloride on human plasma high density lipoproteins.

  1976cited by this paper
• Studies on human serum high density lipoproteins. Self-association of apolipoprotein A-I in aqueous solutions.

  1976cited by this paper

• ApoA-I dissociated from human HDL retains its acceptor properties in ABCA1-mediated cholesterol efflux from RAW 264.7 macrophages in coronary artery disease

  2025cites this paper
• Understanding HDL Metabolism and Biology Through In Vivo Tracer Kinetics.

  2023cites this paper
• Different Pathways of Cellular Cholesterol Efflux

  2022cites this paper
• Serum opacity factor rescues fertility among female Scarb1−/− mice by reducing HDL-free cholesterol bioavailability

  2022cites this paper
• Denaturation of human plasma high-density lipoproteins by urea studied by apolipoprotein A-I dissociation.

  2020cites this paper
• High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes.

  2019cites this paper
• Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans.

  2019cites this paper
• Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.

  2018cites this paper
• Effects of Disease-Causing Mutations on the Conformation of Human Apolipoprotein A-I in Model Lipoproteins.

  2018cites this paper
• Structural Stability of Streptococcal Serum Opacity Factor

  2017cites this paper
• Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester

  2017cites this paper
• ABCA1-Derived Nascent High-Density Lipoprotein–Apolipoprotein AI and Lipids Metabolically Segregate

  2017cites this paper
• Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease

  2017cites this paper
• Effects of aspirin in combination with EPA and DHA on HDL-C cholesterol and ApoA1 exchange in individuals with type 2 diabetes mellitus.

  2017cites this paper
• Speciated High-Density Lipoprotein Biogenesis and Functionality

  2016cites this paper
• Therapeutic applications of reconstituted HDL: When structure meets function.

  2016cites this paper
• New Insights into the High-Density Lipoprotein Dilemma.

  2016cites this paper
• Acylation of lysine residues in human plasma high density lipoprotein increases stability and plasma clearance in vivo.

  2016cites this paper
• Neo High-Density Lipoprotein Produced by the Streptococcal Serum Opacity Factor Activity against Human High-Density Lipoproteins Is Hepatically Removed via Dual Mechanisms.

  2016cites this paper
• HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity

  2015cites this paper
• Kinetic and thermodynamic analyses of spontaneous exchange between high-density lipoprotein-bound and lipid-free apolipoprotein A-I.

  2015cites this paper
• Structural stability and functional remodeling of high‐density lipoproteins

  2015cites this paper
• Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism.

  2015cites this paper
• HDL-cholesterol in coronary artery disease risk: function or structure?

  2014cites this paper
• The Structure and Function of SerumOpacity Factor : A Unique Streptococcal Virulence Determinant That Targets High-Density Lipoproteins

  2014cites this paper
• Comparison of apoA-I helical structure and stability in discoidal and spherical HDL particles by HX and mass spectrometry

  2013cites this paper
• Interactions of Apolipoprotein A-I with High-Density Lipoprotein Particles

  2013cites this paper
• HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis

  2013cites this paper
• Impaired Lipoprotein Processing in HIV Patients on Antiretroviral Therapy: Aberrant High-Density Lipoprotein Lipids, Stability, and Function

  2013cites this paper
• Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells[S]

  2012cites this paper
• New insights into the determination of HDL structure by apolipoproteins1

  2012cites this paper
• ATP binding cassette transporter A1 (ABCA1) associated proteins: potential drug targets in the metabolic syndrome and atherosclerotic disease?

  2012cites this paper
• The origin and metabolism of a nascent pre-β high density lipoprotein involved in cellular cholesterol efflux.

  2011cites this paper
• Surface plasmon resonance analysis of the mechanism of binding of apoA-I to high density lipoprotein particles

  2010cites this paper
• HDL superphospholipidation enhances key steps in reverse cholesterol transport.

  2010cites this paper
• The Structure and Function of Serum Opacity Factor: A Unique Streptococcal Virulence Determinant That Targets High-Density Lipoproteins

  2010cites this paper
• Exchange of Apolipoprotein A-I between Lipid-associated and Lipid-free States

  2010cites this paper
• Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.

  2009cites this paper
• Differential stability of high-density lipoprotein subclasses: effects of particle size and protein composition.

  2009cites this paper
• Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I.

  2009cites this paper
• Human Plasma Lipoprotein Metabolism

  2009cites this paper
• Conformational flexibility of the N-terminal domain of apolipoprotein a-I bound to spherical lipid particles.

  2008cites this paper
• Properties of the products formed by the activity of serum opacity factor against human plasma high-density lipoproteins.

  2008cites this paper
• Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides Published, JLR Papers in Press, June 14, 2007.

  2007cites this paper
• Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption.

  2007cites this paper